Finding of Myasthenia Gravis After Surgical Removal of Thymus May Signal Cancer’s Return, Case Study Finds
Between 30 percent and 50 percent of all thymoma patients – people treated for a tumor in the thymus gland…
Articles by Patricia Inacio, PhD
Successful Thymus Tumor Surgery in Myasthenia Gravis Patient with Respiratory Distress Reported in Case Study
Careful patient assessment and planning prior to surgery was needed to successfully remove a tumor from the thymus of a myasthenia…
#AAN2018- Ra Pharma’s Myasthenia Gravis Therapy Shows Promise in Phase 1 Trial with Healthy Volunteers
Ra Pharma’s RA101495, a potential treatment for generalized myasthenia gravis patients, showed preliminary signs of halting red blood cell destruction…
Myasthenia Gravis Patients Appear to Have Lower Vitamin D Levels, Study Confirms
Myasthenia gravis patients appear to have lower levels of vitamin D than the general population, a study confirmed. The confirmation…
Levels of Specific MicroRNA a Potential Biomarker for Myasthenia Gravis, Study Shows
Blood levels of a microRNA called miR-150-5p have been identified as a potential biomarker for AChR-positive myasthenia gravis, after surgical…
Robotic-assisted Thymus Surgery Outcomes Are Better Without Immunosuppressants, Study Finds
Using robotic-assisted surgery to remove the thymus without putting a patient on an  immunosuppressant afterwards leads to higher myasthenia gravis (MG) improvement…
Ra Pharma, with Phase 2 Trial Recruiting MG Patients, Joins in Rare Disease Day
Ra Pharmaceuticals, which is now enrolling patients with generalized myasthenia gravis into a Phase 2 clinical trial, joined millions…
Opdivo Treatment Linked to Myasthenia Gravis Relapse in Case Study
Researchers in Japan wrote about a new case study where treatment with the immunotherapy Opdivo (nivolumab) led to a…
Women with MuSK-MG Can Have Safe Pregnancies, Small Study Suggests
Women with a rare form of myasthenia gravis (MG) called muscle specific kinase (MuSK) MG can have healthy pregnancies without…
Phase 1 Trial of GTP-004 Initiated as Therapy for Myasthenia Gravis Treatment Side Effects
GT Biopharma has launched a proof-of-concept Phase 1 trial of its investigational therapy GTP-004 for the treatment of myasthenia…